Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Conference Poster
type: Class

Entity
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

2014
type: Class

RDF description of Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid - http://research.umh.es/vivo/pub/comunicacion/154953
type: Document
rights: termsOfUse
date: 2026-08-03T07:30:58
publisher: Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid

Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid
type: Continuant
RO_0002353: TWENTY-THIRD POPULATION APPROACH GROUP IN EUROPE
type: 2014
related by: Autor:152123-Comunicación:154953
most specific type: Conference Poster
type: Thing
type: Document
type: Conference Poster
ARG_2000028: 154953 vcard
related by: AutorExt:241889_2014-Comunicación:154953
related by: AutorExt:241888_2014-Comunicación:154953
date time value: 154953 pubdate
type: Entity
type: Anualidad
related by: AutorExt:241886_2014-Comunicación:154953
most specific type: 2014
related by: AutorExt:241890_2014-Comunicación:154953
most specific type: Congress communication
related by: Autor:152399-Comunicación:154953
related by: AutorExt:241887_2014-Comunicación:154953
type: Information Content Entity
type: Generically Dependent Continuant
type: Congress communication

TWENTY-THIRD POPULATION APPROACH GROUP IN EUROPE
type: Anualidad
type: BFO_0000003
RO_0002234: Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid
type: BFO_0000015
type: Event
type: Thing
type: Conference
type: Entity
type: 2014

Autor:152123-Comunicación:154953
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid

AutorExt:241889_2014-Comunicación:154953
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid

AutorExt:241888_2014-Comunicación:154953
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid

AutorExt:241886_2014-Comunicación:154953
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid

AutorExt:241890_2014-Comunicación:154953
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid

Autor:152399-Comunicación:154953
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid

AutorExt:241887_2014-Comunicación:154953
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Semiphysiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid